InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Baffa Raffaele, Directeur Médical. Insider active across 1 company, notably Ziopharm Oncology INC. Cumulatively, 2 reports have been published. History available since 17 May 2021. The latest transaction was filed on 17 May 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Raffaele Baffa is the Chief Medical Officer at ZIOPHARM Oncology Inc., a biopharmaceutical company specializing in cancer treatment. In this role, he oversees clinical and research initiatives, contributing to innovation in oncology treatments.